Summary:

Dengue has been recognized as the most frequent arboviral infection in tropical and sub-tropical regions of the world, with an estimated 390 million people infected each year, and 100 million developing illness. The disease is spreading to new areas including Europe. Autochthonous cases are now observed on an almost annual basis in many European countries, with the risk of local outbreaks where the mosquito vector exists. Among ill travellers returning from some regions, eg South-East Asia, the Caribbean etc. dengue is the most diagnosed cause of fever. With global warming and increased urbanization, dengue will continue to pose a threat to endemic populations as well as travellers.

This webinar is Series 2 of 2 of Dengue and COVID-19 focused webinars. You can find Series 1 on the webinar page of the LMS.

Attendee Takeaways:

1. Risk factors for contracting dengue in travellers
2. Clinical manifestations of dengue in travellers vs those in endemic populations
3. Enhanced understanding of cost-of-illness related to dengue in travellers
4. The importance of pretravel consultation in preventing dengue in traveller

By the end of this webinar, the attendee should be able to:

1. Discuss the epidemiology of dengue in travelers.
2. Discuss the latest data on cost-of-illness related to dengue in travellers.
3. Examine the effectiveness of commonly advised personal protection measures to prevent dengue in travellers

Who Should Attend:

1. Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists

2. Travel Health Practitioners – Doctors, Nurses, and Pharmacists

3. Public Health Practitioners

4. Family Medicine Practitioners

5. Any others who care for travelers and migrants

Note:

You must register to attend the webinar. The Zoom link will be provided in your registration email or you may attend by accessing the webinar on your LEARNING @ ISTM dashboard.